Building Partnerships

Marshall Goldsmith

Many leaders will be operating more like the managing director of a consulting firm. Future leaders will work with their managers in a team approach that combines the leader’s knowledge of unit operations with the manager’s understanding of larger needs. The same trend is occurring in pharmaceuticals and telecommunications. The ideal leader is a person who builds internal and external partnerships. by Marshall Goldsmith.

Why Apple Has to Become More Open

Harvard Business Review

At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. Android, the open-source software platform developed by Google, quickly became the dominant operating system in the mobile marketplace.

Avoiding the Schizophrenic IT Organization

Harvard Business Review

A pharmaceuticals company we''ve been studying decided to deploy more than 20,000 iPads and other mobile devices to the global sales force to improve its engagement with doctors in emerging and developed markets.

CIO 16

The Sequestration Cuts that Are Harming Health Care

Harvard Business Review

Between October 1 and 17, the federal government ceased all nonessential operations because of a partisan stalemate over Obamacare. noted the irony that because of sequester cuts, NIH funding was reduced for the research that resulted in Yale’s James Rothman sharing in the 2013 Nobel Prize for Medicine. Cuts to 2013 budget : $285 Million or 5%. Cuts to 2013 budget: $11.08 Cuts to 2013 budget : $209 Million or 5%.

Joining Boards: It's Not Just Who You Know That Matters

Harvard Business Review

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., For many, a corporate directorship is a career capstone. But attaining one is far from easy.

Parting Ways with Public Trading

Harvard Business Review

Such a pattern is well established in the pharmaceutical industry as large established firms partner with smaller biotech firms. As Dell''s public statements have pronounced, these changes will reduce near-term profitability, raise operating and capital expenditures and involve a lot of risk.

Get Ready for the New Era of Global Manufacturing

Harvard Business Review

We see advances in materials, processes, and information technology that will make possible entirely new kinds of products and can radically alter how manufacturers operate. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines.

Why Apple Has to Become More Open

Harvard Business Review

At the moment Apple can get away with this behavior, because it so powerful in the niche markets in which it operates and it has a small array of products. Android, the open-source software platform developed by Google, quickly became the dominant operating system in the mobile marketplace.

Business Needs to Do What Government Can't

Harvard Business Review

Perhaps surprisingly, two leading examples come from pharmaceutical companies. We're moving towards innovation in technology, pricing, business models and partnerships," explains head of corporate responsibility management, Dorje Mundle, of the company's base-of-the-pyramid operations.

What Is Organizational Culture? And Why Should We Care?

Harvard Business Review

Beginning May 1, 2013, I facilitated a discussion around this question on LinkedIn. Organizational culture is shaped by and overlaps with other cultures — especially the broader culture of the societies in which it operates. This observation highlights the challenges that global organizations face in establishing and maintaining a unified culture when operating in the context of multiple national, regional and local cultures.

Scaling: The Problem of More

Harvard Business Review

We studied how Wyeth, the large Pharmaceutical firm (now part of Pfizer) made dramatic improvements in cost and quality across its manufacturing operation. Start talking about the challenge of “scaling” with people, and you’ll find the term gets used to mean a lot of different things. For example, when entrepreneurs talk about it, they are usually struggling with matters of organization.

Filing for a Patent Versus Keeping Your Invention a Trade Secret

Harvard Business Review

Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. At the same time, trade secrets are viewed as the stepchild of intellectual property because they operate, by definition, in secrecy, and we know much less about their role in market competition than we know about patents, copyrights, and trademarks. For many years, beginning in 1942, Premarin was the only hormone replacement therapy drug on the market derived from a natural source.

How Not to Lose a Sale

Harvard Business Review

Robyn*, a close friend of mine and senior leader at a large pharmaceutical company, referred me to work with Dan, the CEO of one of her company's subsidiaries and someone she knew well. I was operating from my perspective. He was operating from his perspective. And from his perspective, the fact that I was operating from my perspective was a deal-breaker.

Go Ahead and Gossip

Harvard Business Review

Carl Kerrigan,* a director of operations at a large pharmaceutical company, sees office gossip as an important communication tool.

Why America Is Losing Its Entrepreneurial Edge

Harvard Business Review

As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. The current corporate entity is comprised of firms that used to be called: King Pharmaceuticals, Wyeth, American Cyanamid, Lederle, Pharmacia, Upjohn, Searle, SUGEN, Warner-Lambert, Parke-Davis and others. The U.S. is one of the few nations on earth where private, for-profit business formation is seen as a quasi-heroic act.

The 3 Things CEOs Worry About the Most

Harvard Business Review

Please note that titles used here reflect the positions the individuals held in 2013, when we conducted the interviews for a separate article ). Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation.

6 Reasons Marketing Is Moving In-House

Harvard Business Review

This continues a trend The Association of National Advertisers first reported in 2013. ” Another brand manager told me that many agencies are creating social spin-offs but they still operate like traditional ad agencies.

The First Step to Fixing U.S. Manufacturing

Harvard Business Review

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. In fact, MGI analysis of financial data shows that large publicly traded US manufacturing firms, most of them multinationals with revenues greater than $500 million, averaged returns on invested capital of 22% from 1997 to 2013.

Four Mistakes to Avoid When Predicting Competitors’ Moves

Harvard Business Review

But for 2013 he was only about 15 percent on target. But his 2013 forecasts were certainly within the realm of the possible; they just failed to materialize this year. Far too often companies watch regulation on a national basis in their countries of operation, missing small regulatory changes occurring in a province or state. Companies in the pharmaceutical industry – particularly in the U.S. –

What to Know About Doing Business in Iran

Harvard Business Review

However, oil prices have dropped more than 60% since the interim nuclear deal in November 2013. And alongside the country’s bad debt (some estimates say it is $40 billion ), sanctions were commonly evaded through money laundering , which discouraged foreign banks from operating locally.

Aligning Your Organization with an Agile Workforce

Harvard Business Review

McKesson, the US-based pharmaceutical and health-care giant, benefits from external expertise as a strategic extension of its resources in areas such as business strategy and logistics support.

How Company Culture Shapes Employee Motivation

Harvard Business Review

One 2013 study illustrates this well. The Chief Talent Officer at UCB Pharmaceuticals told us how he recently started inviting patients to executive meetings, so the people making decisions can see how their work makes a difference. DAVE WHEELER FOR HBR.

Navigating the Dozens of Different Strategy Options

Harvard Business Review

Tata Consultancy Services, the India-based information technology (IT) services and solutions company, operates in an environment it can neither predict nor change. The strategy palette can therefore guide not only the strategic intentions but also the operational setup of a company.